Lord, Abbett & Co. LLC Vericel Corp Transaction History
Lord, Abbett & Co. LLC
- $28.1 Billion
- Q1 2025
A detailed history of Lord, Abbett & Co. LLC transactions in Vericel Corp stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 121,278 shares of VCEL stock, worth $4.96 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
121,278
Previous 112,790
7.53%
Holding current value
$4.96 Million
Previous $6.19 Million
12.63%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding VCEL
# of Institutions
291Shares Held
52.1MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$330 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$143 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.88MShares$118 Million3.98% of portfolio
-
State Street Corp Boston, MA2.44MShares$99.7 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.27MShares$93 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.93B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...